Key result
Hypertension in men is linked to elevated beta-TG and PF4 levels that rise with stage.
Observational (n=258)
Plasma levels of beta-thromboglobulin and platelet factor 4 are elevated in essential hypertension and correlate with disease stage, serving as indicators of in vivo platelet activation.
Answers are grounded in this paper and cite their sources.
May reflect platelet activation in hypertension; hypothesis-generating for biomarker utility, requiring prospective validation before clinical use.
Plasma beta-thromboglobulin (beta TG) and platelet factor 4 (PF4) were significantly higher in a group of 116 hypertensive men than in a normotensive group of 142 men. They increased with the stage of hypertension but the level did not correlate with the age of the subjects. Platelet aggregation was similar in the two groups and positively correlated with the age of the subjects in the normotensive group but not in the hypertensive group. A strong positive correlation was observed between the levels of plasma beta TG and PF4 and between platelet aggregation to ADP and that to epinephrine in both the hypertensive and normotensive groups. However, there was no correlation between the level of plasma beta TG or PF4 and platelet aggregation. Plasma antithrombin III was lower in the hypertensive group than in the normotensive group. These studies suggest that plasma levels of beta TG and PF4 are closely related to the stage of hypertension and are better indicators than aggregation of in vivo platelet activation in hypertensive subjects. Enhanced platelet activation may be involved in the acceleration of hypertensive arteriovascular damage and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Yamanishi et al. (1985) conducted an observational in Essential Hypertension (n=258). Essential hypertension vs. Normotensive was evaluated on Plasma beta-thromboglobulin (beta TG) and platelet factor 4 (PF4) levels.
Synapse has enriched 10 related papers. Consider them for comparative context: